CompletedNot Applicable

Comparative Effects of Muscle Energy Technique and Modified Active Release Technique in Scapulocostal Syndrome.

Pakistan46 participantsStarted 2025-01-10

Plain-language summary

The study was conducted to determine the comparative effects of Muscle Energy Technique and Modified Active Release Technique on Pain, Chest expansion and Functional disability in patients with Scapulocostal Syndrome.

Who can participate

Age range

18 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18-40 yrs. * Both male and females with shoulder-neck pain. * NPRS value\> than 3. * Chest expansion value \< than 3cm are included. * Subjects with Upper Trapezius, Levator Scapulae and Rhomboid muscles tenderness. * Pain duration should be present for at least for 3 months before inclusion in the study. * Presence of 1 to 3 trigger points in upper trapezius, levator scapulae, and rhombhoids (MTrP) causing referred pain pattern with palpable taut band of muscle. Exclusion Criteria: * Thoracic outlet syndrome. * Brachial neuralgia. * Local neck and shoulder disorder. * Adhesive Capsulitis. * Cervical Radiculopathy. * Trauma or Injury around Scapular area. * Past Surgical Area. * Any cardiovascular or Respiratory pathology. * People with psychiatric illness such as depression.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Numeric Pain Rating Scale

Timeframe: From enrollment to the end of treament at 6 weeks.

Neck Disability Index.

Timeframe: From enrollment to the end of treatment at 6 weeks

Measuring Inches Tape

Timeframe: From enrollment to the end of study at 6 weeks

Trial details

NCT IDNCT07403227

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-28

View on ClinicalTrials.gov More Scapulocostal Syndrome trials

Who can participate

Age range

18 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.